113 related articles for article (PubMed ID: 2784753)
1. Increase of serum interleukin 2 receptor level in thermally injured patients.
Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Falk RE; Peters WJ
Clin Immunol Immunopathol; 1989 May; 51(2):205-15. PubMed ID: 2784753
[TBL] [Abstract][Full Text] [Related]
2. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression follows systemic T lymphocyte activation in the burn patient.
Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Peters WJ
Clin Exp Immunol; 1991 Sep; 85(3):515-8. PubMed ID: 1893634
[TBL] [Abstract][Full Text] [Related]
4. Expression and secretion of IL-2 receptor in trauma patients.
Teodorczyk-Injeyan JA; McRitchie DI; Peters WJ; Lalani S; Girotti MJ
Ann Surg; 1990 Aug; 212(2):202-8. PubMed ID: 2142878
[TBL] [Abstract][Full Text] [Related]
5. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-2 receptor levels in patients with dermatitis herpetiformis.
Ward MM; Pisetsky DS; Hall RP
J Invest Dermatol; 1991 Sep; 97(3):568-72. PubMed ID: 1875055
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.
Correia O; Delgado L; Roujeau JC; Le Cleach L; Fleming-Torrinha JA
Arch Dermatol; 2002 Jan; 138(1):29-32. PubMed ID: 11790164
[TBL] [Abstract][Full Text] [Related]
8. [Effects of hyperbaric oxygen therapy on the changes in serum sIL-2R and Fn in severe burn patients].
Xu N; Li Z; Luo X
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 May; 15(3):220-3. PubMed ID: 11501128
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis.
Takahashi S; Setoguchi Y; Nukiwa T; Kira S
Chest; 1991 Feb; 99(2):310-4. PubMed ID: 1989787
[TBL] [Abstract][Full Text] [Related]
10. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.
Brynskov J; Tvede N
Gut; 1990 Jul; 31(7):795-9. PubMed ID: 2370014
[TBL] [Abstract][Full Text] [Related]
11. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers.
Sun A; Chu CT; Liu BY; Wang JT; Leu JS; Chiang CP
Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):116-22. PubMed ID: 10943944
[TBL] [Abstract][Full Text] [Related]
13. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis.
Barral-Netto M; Barral A; Santos SB; Carvalho EM; Badaro R; Rocha H; Reed SG; Johnson WD
J Immunol; 1991 Jul; 147(1):281-4. PubMed ID: 1904902
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble interleukin-2 receptor levels in patients with adult T-cell leukemia and human T-cell leukemia/lymphoma virus type-I seropositive healthy carriers.
Motoi T; Uchiyama T; Uchino H; Ueda R; Araki K
Jpn J Cancer Res; 1988 May; 79(5):593-9. PubMed ID: 2900231
[TBL] [Abstract][Full Text] [Related]
15. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
Ward MM; Dooley MA; Christenson VD; Pisetsky DS
J Rheumatol; 1991 Feb; 18(2):235-40. PubMed ID: 2023217
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo?
Dummer R; Posseckert G; Nestle F; Witzgall R; Burger M; Becker JC; Schäfer E; Wiede J; Sebald W; Burg G
J Invest Dermatol; 1992 Jan; 98(1):50-4. PubMed ID: 1728640
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin 2-receptor alpha secretion is related to altered interleukin 2 production in thermally injured patients.
Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Peters WJ
Burns; 1991 Aug; 17(4):290-5. PubMed ID: 1930662
[TBL] [Abstract][Full Text] [Related]
18. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
Simsek H; Kadayifci A
J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
[TBL] [Abstract][Full Text] [Related]
20. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
